XML 41 R25.htm IDEA: XBRL DOCUMENT v3.20.2

Revenue (Tables)

3 Months Ended

Sep. 30, 2020

Revenue from Contract with Customer [Abstract]

Schedule of Total Revenue by Product and by U.S versus Rest of World

The following table presents detail regarding the composition of our total revenue by product and by U.S. versus rest of world, “RoW”:

			Three months ended September 30,
			2020																		2019
(In millions)			U.S.						RoW						Total						U.S.						RoW						Total
Molecular diagnostic revenues:
Hereditary Cancer Testing			$	72.1					$	8.5					$	80.6					$	100.6					$	3.9					$	104.5
Prenatal			16.4						0.1						16.5						23.5						—						23.5
GeneSight			11.9						—						11.9						22.7						—						22.7
Vectra			9.1						—						9.1						11.0						—						11.0
myChoice CDx			7.6						0.2						7.8						1.3						—						1.3
Prolaris			6.4						—						6.4						6.5						—						6.5
EndoPredict			0.4						2.4						2.8						0.5						1.8						2.3
Other			0.6						—						0.6						0.1						0.1						0.2
Total molecular diagnostic revenue			124.5						11.2						135.7						166.2						5.8						172.0
Pharmaceutical and clinical service revenue			9.5						—						9.5						8.5						5.9						14.3
Total revenue			$	134.0					$	11.2					$	145.2					$	174.7					$	11.7					$	186.3

Reconciliation of Deferred Revenue Balances

A reconciliation of the beginning and ending balances of deferred revenue is shown in the table below:

			Three months ended September 30,
			2020						2019
Deferred revenue - beginning balance			$	32.8					$	2.2
Revenue recognized			(2.3)						(0.4)
Prepayments			1.8						0.3
Deferred revenue - ending balance			$	32.3					$	2.1

X

- Definition

Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045

+ Details

Name:	us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration